2009
DOI: 10.1016/j.diabres.2009.04.025
|View full text |Cite
|
Sign up to set email alerts
|

External validation of a clinical scoring system for the risk of gestational diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 9 publications
1
13
0
Order By: Relevance
“…Our study differs from previous validation studies [15][16][17][18] by performing a head-tohead comparison, whereas other studies validated a single prognostic model or only a small selection of the prognostic models for gestational diabetes mellitus. However, our findings are similar to those of these external validation studies, except for the external validation of the Van Leeuwen 2010 model by Lovati and colleagues.…”
Section: Comparison With Other Studiesmentioning
confidence: 84%
See 1 more Smart Citation
“…Our study differs from previous validation studies [15][16][17][18] by performing a head-tohead comparison, whereas other studies validated a single prognostic model or only a small selection of the prognostic models for gestational diabetes mellitus. However, our findings are similar to those of these external validation studies, except for the external validation of the Van Leeuwen 2010 model by Lovati and colleagues.…”
Section: Comparison With Other Studiesmentioning
confidence: 84%
“…However, these prognostic models are not commonly used in routine clinical care nor are they recommended by current guidelines. This might be due to the fact that external validation of these prognostic models are scarce, [15][16][17][18] let alone that all these models have been directly evaluated and compared on the basis of their predictive accuracy in one independent cohort by independent investigators. To acquire a fair comparison of their predictive accuracy, and thus of their clinical value, it is essential to perform a head-to-head comparison of all published prognostic models in one independent cohort.…”
Section: What This Study Addsmentioning
confidence: 99%
“…Reference cross-checking of the selected papers yielded no additional studies. Thus, a total of 17 studies on firsttrimester prediction modeling for GDM were identified for inclusion in this review [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]. Fourteen studies were development studies and another three studies were external validation studies.…”
Section: Study Selectionmentioning
confidence: 99%
“…These inconsistencies draw attention to the importance of taking into consideration the unique research situation on the enactment of ethnicity. For example, the cohort study participants from the Van Leeuwen et al (2010) article discussed above are, in a different publication, recategorised from the original country-of-origin categories into the racial categories ''Caucasian'', ''Black'', ''Asian'', and ''Other'' (instead of ''Caucasian'' and ''non-Caucasian'', as in the first article discussed above) (Van Leeuwen et al, 2009. Thus, the same data are categorised into different racialised groups in different publications by the same authors.…”
Section: Multiplicitymentioning
confidence: 99%
“…Hispanic American, Native American, Asian American, African American, and Pacific Islander)'' (American Diabetes Association, 2009: S66), a phrase which is transformed by the authors into ''non-Caucasian'', after they found that the individual country-of-origin ethnic groups were too small for any meaningful statistical analysis to take place. In the second article based on the same cohort study, the authors refer specifically to a different model developed by Naylor et al, (1997) in which the clinical risk groups are described as ''Black'', ''Asian'', and ''Other'', with ''White'' being used as a reference group (Naylor et al, 1997. in Van Leeuwen et al, 2009).…”
Section: Multiplicitymentioning
confidence: 99%